High-Risk Drug Class Audit
Updated 2024
Anticonvulsant and Sedative Hypnotic added!
To prepare for assessment and encoding of MDS v1.19.1 Section N, the Briggs High-Risk Drug Class Audit is used with each resident that receives any one or more of the drug classes identified as taken during the 7-day look-back period. Included in the audit are these prompts:
| • | Identification of the high-risk drug class |
| • | Name of the drug |
| • | Physician diagnosis or indication for the drug administered |
| • | Dosage and frequency |
| • | Date drug initiated |
| • | Identification of the prescribing physician/physician extender |
| • | Location of diagnosis/indication for the use of the drug present within the resident's medical record |
| • | Orders for labs pertinent to the administration of the drug as well as monitoring for adverse reactions on the resident-specific care plan |
| • | Space for additional notes and comments pertinent to the audit |
Size: 11" x 8 ½"
Paper: White
Print: Black ink, 2-sides different
Punching: 5-holes top and side
Packaging: 100 per pad